These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21183147)

  • 1. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.
    Shah NK; Dhillon GP; Dash AP; Arora U; Meshnick SR; Valecha N
    Lancet Infect Dis; 2011 Jan; 11(1):57-64. PubMed ID: 21183147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.
    Mishra N; Srivastava B; Bharti RS; Rana R; Kaitholia K; Anvikar AR; Das MK; Ghosh SK; Bhatt RM; Tyagi PK; Dev V; Phookan S; Wattal SL; Sonal GS; Dhariwal AC; Valecha N
    J Vector Borne Dis; 2016; 53(2):168-78. PubMed ID: 27353588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
    Mishra N; Kaitholia K; Srivastava B; Shah NK; Narayan JP; Dev V; Phookan S; Anvikar AR; Rana R; Bharti RS; Sonal GS; Dhariwal AC; Valecha N
    Malar J; 2014 Jul; 13():284. PubMed ID: 25052385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.
    Garg MR; Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
    Das Sutar SK; Dhangadamajhi G; Kar SK; Ranjit M
    Acta Trop; 2013 Apr; 126(1):84-7. PubMed ID: 23357175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998.
    Ndyomugyenyi R; Magnussen P
    Acta Trop; 2000 Oct; 76(3):265-70. PubMed ID: 10974167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia.
    Osorio LE; Giraldo LE; Grajales LF; Arriaga AL; Andrade AL; Ruebush TK; Barat LM
    Am J Trop Med Hyg; 1999 Dec; 61(6):968-72. PubMed ID: 10674680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata.
    Basu A; Saha S; Guha SK
    J Assoc Physicians India; 2015 May; 63(5):32-7. PubMed ID: 26591142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010.
    Mishra N; Singh JP; Srivastava B; Arora U; Shah NK; Ghosh SK; Bhatt RM; Sharma SK; Das MK; Kumar A; Anvikar AR; Kaitholia K; Gupta R; Sonal GS; Dhariwal AC; Valecha N
    Bull World Health Organ; 2012 Dec; 90(12):895-904. PubMed ID: 23284195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
    Tjitra E; Suprianto S; Currie BJ; Morris PS; Saunders JR; Anstey NM
    Am J Trop Med Hyg; 2001 Oct; 65(4):309-17. PubMed ID: 11693875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evidence for
    Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
    Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
    Mullick S; Das S; Guha SK; Bera DK; Sengupta S; Roy D; Saha P; Biswas A; Das M; Ray K; Kundu PK; Maji AK
    Trop Med Int Health; 2011 Aug; 16(8):929-35. PubMed ID: 21564429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
    Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.